Breaking News Instant updates and real-time market news.

GE

General Electric

$12.97

-0.08 (-0.61%)

06:11
04/12/18
04/12
06:11
04/12/18
06:11

GE exploring spinoffs, 'hybrid' deals in strategic review, WSJ reports

General Electric is exploring a public offering for one of its divisions and discussing "hybrid" deals with public companies to combine assets, The Wall Street Journal reports, citing people familiar with the matter. The hybrid deals would leave GE shareholders with stakes in multiple public companies, the report says. Possibilities include spinning off a unit to investors or combining a unit with a smaller public company "in a way that avoids a big tax bill." Some of the people say GE Transportation "could be a model," as GE is said to be preparing for an IPO or spinoff of the division; the unit could be merged with another company that would leave GE shareholders in control of a new public company, one person says. Reference Link

  • 20

    Apr

GE General Electric
$12.97

-0.08 (-0.61%)

04/06/18
JPMS
04/06/18
NO CHANGE
Target $11
JPMS
Underweight
General Electric's 2018 closer to normal than many think, says JPMorgan
JPMorgan analyst Stephen Tusa sees downside risk to estimates for General Electric in the near term. In a fresh research note titled "'Normal' is a Relative Term: A Fresh Look at The GE Power Model," Tusa says his 2018 estimates for GE remain below consensus. Debate continues around the sum-of-the-parts and what could be done to unlock value, Tusa writes. He believes that after nine months in the role, management is likely to have a "better story to tell than the one they told in November the next time we hear from them." GE is already discussing actively with some investors the path forward for improvement off of what is perceived to be depressed operating levels, the analyst reveals. Tusa believes, however, that GE's 2018 is closer to "normal" than many think. The analyst sees support for his Underweight rating on the shares with an $11 price target. General Electric closed yesterday up 15c to $13.43.
04/09/18
JPMS
04/09/18
NO CHANGE
Target $11
JPMS
Underweight
General Electric is most expensive stock in sector, says JPMorgan
After getting feedback from his research note on Friday, JPMorgan analyst Stephen Tusa put out a new note titled "Yes, GE Is The Most Expensive Stock In the Sector." The analyst has an Underweight rating on shares of General Electric with an $11 price target. The stock closed Friday down 37c to $13.06. He believes any recovery in the company's Power unit will be back end loaded into next decade. Tusa also sees a run rate on free cash flow that is "significantly lower" than the prevailing $1 "bull case narrative." GE is the most expensive stock in the sector, he proclaims.
04/11/18
COWN
04/11/18
NO CHANGE
Target $12
COWN
Market Perform
Cowen says avoid General Electric ahead of earnings, lowers target to $12
Cowen analyst Gautam Khanna lowered his price target on General Electric to $12 from $15 and told investors to avoid the shares heading into its restatement of prior earning and its Q1 results. He believes the restatement will continue to pressure the shares, calling GE a "show-me" stock. Khanna, who thinks a Q1 EPS miss appears probable and that GE's 2018 guidance overstate its earnings base, maintained his Market Perform rating on General Electric shares.
04/11/18
COWN
04/11/18
NO CHANGE
Target $12
COWN
Market Perform
Cowen says avoid GE into earnings report, cuts price target to $12
The upcoming accounting restatement and Q1 earnings report will continue to pressure shares of General Electric, which is now a "show me" stock, Cowen analyst Gautam Khan tells investors in a research note titled "Avoid Into Restatement and Q1 Print". The analyst sees an earnings miss in Q1 as probable, with his adjusted earnings per share estimate of 8c below the consensus of 12c. Further, he believes General Electric's 2018 guidance overstates its earnings base. GE's $1.00-$1.07 adjusted earnings per share outlook for 2018 excludes $3.2B of pension and $2.5B of restructuring expenses, which have a 55c negative impact to GAAP earnings per share, Khan points out. In addition, he believes GE's 2017 restatement may be a negative if it raises the company's cost to borrow. Khan cut his price target for GE shares to $12 from $15 and keeps a Market Perform rating on the name. The stock closed yesterday at $13.05.

TODAY'S FREE FLY STORIES

KBR

KBR

$17.09

-0.06 (-0.35%)

06:04
04/19/18
04/19
06:04
04/19/18
06:04
Hot Stocks
KBR acquires Carillion's interests in Aspire Defence joint venture »

KBR announced, following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    Jun

  • 25

    Jun

GTLS

Chart Industries

$60.57

-0.22 (-0.36%)

06:03
04/19/18
04/19
06:03
04/19/18
06:03
Earnings
Chart Industries reports Q1 adjusted EPS 23c, consensus 19c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 17

    May

  • 29

    May

  • 29

    Aug

  • 30

    Aug

BBT

BB&T

$50.62

-0.47 (-0.92%)

06:03
04/19/18
04/19
06:03
04/19/18
06:03
Earnings
BB&T reports Q1 EPS 94c, consensus 92c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 24

    Apr

GOOG

Alphabet

$1,072.25

-2.17 (-0.20%)

, GOOGL

Alphabet Class A

$1,075.28

-4.12 (-0.38%)

06:02
04/19/18
04/19
06:02
04/19/18
06:02
Periodicals
Google Pay surpasses 100M downloads on Play Store, Android Police says »

Google Pay, called…

GOOG

Alphabet

$1,072.25

-2.17 (-0.20%)

GOOGL

Alphabet Class A

$1,075.28

-4.12 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

INTC

Intel

$53.61

0.08 (0.15%)

06:01
04/19/18
04/19
06:01
04/19/18
06:01
Periodicals
Intel plans to shut down New Devices Group, The Information reports »

Intel plans to shut down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$25.86

0.86 (3.44%)

05:59
04/19/18
04/19
05:59
04/19/18
05:59
Hot Stocks
Adamas Pharmaceuticals announces final results from GOCOVRI Phase 3 study »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 25

    Apr

  • 25

    Apr

  • 12

    Jun

TSLA

Tesla

$293.42

5.8 (2.02%)

05:55
04/19/18
04/19
05:55
04/19/18
05:55
Hot Stocks
Tesla batteries delivering power at 662 locations in Puerto Rico, Musk says »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$109.31

-0.9 (-0.82%)

05:55
04/19/18
04/19
05:55
04/19/18
05:55
Hot Stocks
JPMorgan Chase announces branch expansion in Greater Washington DC »

JPMorgan Chase announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 30

    May

  • 13

    Jul

  • 12

    Oct

ICLK

iClick Interactive Asia

$7.76

0.19 (2.51%)

05:55
04/19/18
04/19
05:55
04/19/18
05:55
Conference/Events
iClick Interactive Asia management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 20

    Apr

SBNY

Signature Bank

$135.08

-1.99 (-1.45%)

05:52
04/19/18
04/19
05:52
04/19/18
05:52
Hot Stocks
Signature Bank reports Q1 EPS ex-items $2.69, consensus $2.67 »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 25

    Apr

SCCO

Southern Copper

$57.33

0.745 (1.32%)

05:50
04/19/18
04/19
05:50
04/19/18
05:50
Downgrade
Southern Copper rating change  »

Southern Copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

FOXA

21st Century Fox

$37.32

-0.22 (-0.59%)

, DIS

Disney

$101.21

-1 (-0.98%)

05:49
04/19/18
04/19
05:49
04/19/18
05:49
Hot Stocks
21st Century Fox rejected rival bid of $34.41 per share for assets »

Disney (DIS) disclosed…

FOXA

21st Century Fox

$37.32

-0.22 (-0.59%)

DIS

Disney

$101.21

-1 (-0.98%)

CMCSA

Comcast

$33.28

0.02 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 09

    May

NTRS

Northern Trust

$106.38

-0.04 (-0.04%)

05:47
04/19/18
04/19
05:47
04/19/18
05:47
Hot Stocks
Northern Trust enters partnership with The Northern Pool »

The Northern Pool has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$81.72

-0.09 (-0.11%)

, AMGN

Amgen

$175.14

0.19 (0.11%)

05:36
04/19/18
04/19
05:36
04/19/18
05:36
Hot Stocks
Novartis appoints John Tsai as Chief Medical Officer, Head of GDD »

Novartis (NVS) announced…

NVS

Novartis

$81.72

-0.09 (-0.11%)

AMGN

Amgen

$175.14

0.19 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

  • 30

    Apr

  • 17

    May

  • 21

    May

  • 28

    May

  • 05

    Jun

AMZN

Amazon.com

$1,527.24

23.92 (1.59%)

05:36
04/19/18
04/19
05:36
04/19/18
05:36
Recommendations
Amazon.com analyst commentary  »

Amazon online retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:34
04/19/18
04/19
05:34
04/19/18
05:34
Earnings
Novartis confirms FY18 revenue guidance of growth of low to mid single-digit »

Novartis noted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:34
04/19/18
04/19
05:34
04/19/18
05:34
Hot Stocks
Novartis reports Q1 Alcon sales of $1.8B »

Alcon net sales were…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

RDN

Radian Group

$15.36

-0.91 (-5.59%)

05:30
04/19/18
04/19
05:30
04/19/18
05:30
Recommendations
Radian Group analyst commentary  »

Radian Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:29
04/19/18
04/19
05:29
04/19/18
05:29
Hot Stocks
Novartis Q1 results continue to demonstrate benefit from turnaround plan actions »

Novartis noted, Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

MTG

MGIC Investment

$10.50

-0.275 (-2.55%)

05:29
04/19/18
04/19
05:29
04/19/18
05:29
Downgrade
MGIC Investment rating change  »

MGIC Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESNT

Essent Group

$34.83

-2.045 (-5.55%)

, MTG

MGIC Investment

$10.50

-0.275 (-2.55%)

05:28
04/19/18
04/19
05:28
04/19/18
05:28
Downgrade
Essent Group, MGIC Investment, Radian Group rating change  »

Essent Group downgraded…

ESNT

Essent Group

$34.83

-2.045 (-5.55%)

MTG

MGIC Investment

$10.50

-0.275 (-2.55%)

RDN

Radian Group

$15.36

-0.91 (-5.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 04

    May

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:27
04/19/18
04/19
05:27
04/19/18
05:27
Hot Stocks
Novartis reports Q1 Sandoz net sales of $2.5B »

Sandoz net sales were…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:25
04/19/18
04/19
05:25
04/19/18
05:25
Earnings
Novartis reports Q1 core EPS $1.28, consensus $1.29 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

PG

Procter & Gamble

$78.19

-0.23 (-0.29%)

, TEVA

Teva

$17.91

0.065 (0.36%)

05:23
04/19/18
04/19
05:23
04/19/18
05:23
Hot Stocks
Procter & Gamble acquires Consumer Health business of Merck KGaA for EUR 3.4B »

Procter & Gamble (PG)…

PG

Procter & Gamble

$78.19

-0.23 (-0.29%)

TEVA

Teva

$17.91

0.065 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 27

    Apr

  • 18

    May

  • 05

    Jun

  • 16

    Jun

GOL

GOL Linhas

$13.51

0.72 (5.63%)

05:22
04/19/18
04/19
05:22
04/19/18
05:22
Downgrade
GOL Linhas rating change  »

GOL Linhas downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.